See All Slides -

Slides

Presentation TCT 2012

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Presenter: Kimberly Selzman

October 23, 2012

Presentation TCT 2012

TCT-29. Radial vs. Femoral Access for Coronary Angiography and Intervention in Patients with Acute Coronary Syndromes: Results of the Zwolle Myocardial Infarction Study Group

Presenter: Rik Hermanides

October 23, 2012

Presentation TCT 2012

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

Presenter: Jan-Henk Dambrink

October 23, 2012

Presentation TCT 2012

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

Presenter: Lon Annest

October 23, 2012

Presentation TCT 2012

Post-Fellowship Skill Training: Proctoring and Beyond

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Presenter: Alexander Kharlamov

October 23, 2012

Presentation TCT 2012

Introduction(12)

Presenter: Peter Brady

October 23, 2012

Advertisement

Slides

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

TCT-29. Radial vs. Femoral Access for Coronary Angiography and Intervention in Patients with Acute Coronary Syndromes: Results of the Zwolle Myocardial Infarction Study Group

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

BioVentrix Minimally Invasive Reshaping of the Anterior Infarcted Heart

Post-Fellowship Skill Training: Proctoring and Beyond

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Viability Testing, Clinical Decision Making(2)

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Introduction(12)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content